LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
1
8.76 27.76 11 401 0.0274 -0.2136
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
8.76 27.76 925 401 2.3059 1.4843
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
10.46 27.76 5 438 0.0114 -0.3498
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
10.46 27.76 867 438 1.9766 1.3732
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
10.46 27.76 74 438 0.1687 0.2792
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
10.46 27.76 957 438 2.1817 1.4328
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
12.17 27.76 7 489 0.0143 -0.2831
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
12.17 27.76 894 489 1.8280 1.3138
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
12.17 27.76 209 489 0.4273 0.6286
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
12.17 27.76 1028 489 2.1019 1.3932
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
13.87 27.76 13 604 0.0215 -0.1569
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
13.87 27.76 895 604 1.4800 1.1844
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
13.87 27.76 715 604 1.1824 1.0768
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
13.87 27.76 1076 604 1.7794 1.2768
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
15.58 27.76 19 685 0.0277 -0.0787
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
15.58 27.76 950 685 1.3857 1.1461
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
15.58 27.76 848 685 1.2369 1.0941
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
15.58 27.76 1084 685 1.5812 1.2082
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
17.28 27.76 27 838 0.0322 -0.0056
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
17.28 27.76 918 838 1.0945 1.0371
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
17.28 27.76 1029 838 1.2269 1.0849
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
17.28 27.76 1171 838 1.3962 1.1405
MN20160318_Q01
K06
MCF 10A-H2B-mCherry Trametinib
1
18.98 27.76 25 941 0.0266 -0.0204
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
18.98 27.76 922 941 0.9797 0.9919
MN20160318_Q01
E15
MCF 10A-H2B-mCherry Trametinib
1
18.98 27.76 976 941 1.0370 1.0144
MN20160318_Q01
K06